0000950170-23-054380.txt : 20231020
0000950170-23-054380.hdr.sgml : 20231020
20231020161638
ACCESSION NUMBER: 0000950170-23-054380
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231018
FILED AS OF DATE: 20231020
DATE AS OF CHANGE: 20231020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adams Laura Lee
CENTRAL INDEX KEY: 0001891764
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 231337336
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
ownership.xml
4
X0508
4
2023-10-18
0001492674
T2 Biosystems, Inc.
TTOO
0001891764
Adams Laura Lee
101 HARTWELL AVENUE
LEXINGTON
MA
02421
true
false
false
false
false
Common Stock
2023-10-18
4
M
false
7
A
37
D
Restricted Stock Units
2023-10-18
4
M
false
7
0.00
D
Common Stock
7
7
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
On October 18, 2021 the reporting person was granted 21 RSU's that vest in three equal annual installments commencing on October 18, 2022.
/s/ John Sprague, Attorney-in-fact
2023-10-20